Previous close | 5.75 |
Open | 5.70 |
Bid | 5.70 x 46300 |
Ask | 5.80 x 43700 |
Day's range | 5.70 - 5.70 |
52-week range | 2.16 - 6.65 |
Volume | |
Avg. volume | 239 |
Market cap | 137.412M |
Beta (5Y monthly) | 1.04 |
PE ratio (TTM) | 7.60 |
EPS (TTM) | 0.75 |
Earnings date | 09 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Generally speaking, investors are inspired to be stock pickers by the potential to find the big winners. You won't get...
NEW YORK, Jan. 29, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Cipher Pharmaceuticals Inc. (TSX: CPH; OTCQX: CPHRF), a specialty pharmaceutical company, has qualified to trade on the OTCQX® Best Market. Cipher Pharmaceuticals Inc. upgraded to OTCQX from the Pink® market. Cipher Pharmaceuticals Inc. begins trading today on OTCQX under the symbol “CPHRF.” U.S. investors can find c
Key Insights Cipher Pharmaceuticals' significant individual investors ownership suggests that the key decisions are...